Genomic Vision Logo

Genomic Vision

GV | XPAR

Overview

Corporate Details

ISIN(s):
FR0011799907
LEI:
969500UXJNBY1C8Y8471
Country:
France
Address:
80 RUE DES MEUNIERS, 92220 BAGNEUX
Sector:
Health Care
Industry:
Biotechnology

Description

GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-11-17 18:00
Inside Information Statement
Inside Information / Other news releases
English 171.1 KB
2023-11-17 18:00
Inside Information Statement
Informations privilégiées / Autres communiqués
French 168.7 KB
2023-11-14 18:00
Earnings Release
Inside Information / News release on accounts, results
English 183.9 KB
2023-11-14 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 182.8 KB
2023-11-08 18:38
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 79.6 KB
2023-11-07 18:00
Inside Information Statement
Informations privilégiées / Autres communiqués
French 165.9 KB
2023-11-03 18:00
Regulatory News Service
Inside Information / Other news releases
English 133.1 KB
2023-11-03 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 134.9 KB
2023-11-02 07:00
Inside Information Statement
Informations privilégiées / Autres communiqués
French 166.5 KB
2023-11-02 07:00
Inside Information Statement
Inside Information / Other news releases
English 165.6 KB
2023-10-24 18:00
Inside Information Statement
Informations privilégiées / Autres communiqués
French 123.8 KB
2023-10-24 18:00
Regulatory News Service
Inside Information / Other news releases
English 122.3 KB
2023-10-19 09:29
Major Shareholding Notification
Franchissement de seuils
French 272.4 KB
2023-10-18 14:49
Regulatory News Service
Franchissement de seuils
French 272.6 KB
2023-10-12 07:00
Inside Information Statement
Informations privilégiées / Autres communiqués
French 157.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC